
Sign up to save your podcasts
Or


Dr. Jason Crowell talks with Dr. Elsmarieke van de Giessen and Emma Coomans about a newly FDA-approved tau-binding radiotracer [18F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients assessed for Alzheimer disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
By American Academy of Neurology4.7
284284 ratings
Dr. Jason Crowell talks with Dr. Elsmarieke van de Giessen and Emma Coomans about a newly FDA-approved tau-binding radiotracer [18F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients assessed for Alzheimer disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.

320 Listeners

497 Listeners

50 Listeners

291 Listeners

3,349 Listeners

13 Listeners

1,146 Listeners

24 Listeners

193 Listeners

515 Listeners

136 Listeners

368 Listeners

190 Listeners

374 Listeners

83 Listeners